Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.17, Iss.5, 2000-05, pp. : 429-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inpatient costs lower with torasemide than furosemide

Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Determining the Effectiveness of Torasemide and Furosemide in Heart Failure: Design of a Randomised Comparison Using the Regenstrief Medical Record System

By Murray M.D.

Clinical Drug Investigation, Vol. 16, Iss. 1, 1998-07 ,pp. : 45-52

Adis International

Access to resources Recommend Favorite

High-Dose Torasemide is Equivalent to High-Dose Furosemide with Hypertonic Saline in the Treatment of Refractory Congestive Heart Failure

By Salvatore Paterna

Clinical Drug Investigation, Vol. 25, Iss. 3, 2005-01 ,pp. : 165-173

Adis International

Access to resources Recommend Favorite

Torasemide outshines furosemide in QOL stakes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 444, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Torasemide: A Pharmacoeconomic Review of its Use in Chronic Heart Failure

By Young M. Plosker G.L.

PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. : 679-703

Adis International

Access to resources Recommend Favorite